Abcellera Biologicsinc Stock In The News
| ABCL Stock | USD 3.90 0.07 1.76% |
The overall news coverage of Abcellera BiologicsInc from major news outlets shows solid bullish sentiment on 7 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Abcellera BiologicsInc's news coverage and content from conventional and social sources shows investors' bearish mood towards Abcellera BiologicsInc. The specific impact of Abcellera BiologicsInc news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Abcellera BiologicsInc's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Abcellera BiologicsInc headlines in addition to utilizing other, more conventional financial analysis modules. Check out Abcellera BiologicsInc Backtesting and Abcellera BiologicsInc Hype Analysis. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
Abcellera |
Abcellera BiologicsInc Today Top News and Investor Outlook
Abcellera BiologicsInc Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Abcellera and other traded companies coverage. We help investors stay connected with Abcellera headlines for the 24th of April to make an informed investment decision based on correlating the impacts of news items on Abcellera Stock performance. Please note that trading solely based on the Abcellera BiologicsInc hype is not for everyone as timely availability and quick action are needed to avoid losses.Abcellera BiologicsInc stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Abcellera earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Abcellera BiologicsInc that are available to investors today. That information is available publicly through Abcellera media outlets and privately through word of mouth or via Abcellera internal channels. However, regardless of the origin, that massive amount of Abcellera data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Abcellera BiologicsInc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Abcellera BiologicsInc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Abcellera BiologicsInc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Abcellera BiologicsInc alpha.
Abcellera Largest EPS Surprises
Earnings surprises can significantly impact Abcellera BiologicsInc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-03 | 2023-06-30 | -0.13 | -0.11 | 0.02 | 15 | ||
2023-11-02 | 2023-09-30 | -0.13 | -0.1 | 0.03 | 23 | ||
2022-11-08 | 2022-09-30 | 0.05 | 0.08 | 0.03 | 60 | ||
2021-11-09 | 2021-09-30 | -0.05 | -0.08 | -0.03 | 60 | ||
2024-02-20 | 2023-12-31 | -0.13 | -0.17 | -0.04 | 30 | ||
2023-02-21 | 2022-12-31 | -0.01 | -0.1 | -0.09 | 900 |
Abcellera BiologicsInc Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Abcellera BiologicsInc Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
23rd of April 2024
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9 percent Last Week at talkmarkets.com
15th of April 2024
Shareholders in AbCellera Biologics are in the red if they invested a year ago - Yahoo Mov... at news.google.com
8th of April 2024
AbCellera advances T-cell cancer therapy with new data at investing.com
28th of March 2024
American Century Companies Inc. Has 4. Million Stake in AbCellera Biologics Inc. - Defense... at news.google.com
22nd of March 2024
Acquisition by Carl Hansen of 920312 shares of Abcellera BiologicsInc at 14.55 subject to ... at Carl Hansen
15th of March 2024
Graham Capital Management L.P. Increases Stock Position in AbCellera Biologics Inc. - Defe... at news.google.com
12th of March 2024
AbCellera Biologics Inc. Receives Consensus Rating of Buy from Analysts - MarketBeat at news.google.com
11th of March 2024
AbCellera gains on antibody collaboration with Biogen at seekingalpha.com
5th of March 2024
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 at businesswire.com
29th of February 2024
After losing 38 percent in the past year, AbCellera Biologics Inc. institutional owners mu... at finance.yahoo.com
21st of February 2024
AbCellera Biologics Inc. Q4 Earnings Taking a Look at Key Metrics Versus Estimates at zacks.com
Abcellera BiologicsInc Investors Sentiment
The influence of Abcellera BiologicsInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abcellera. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Abcellera BiologicsInc's public news can be used to forecast risks associated with an investment in Abcellera. The trend in average sentiment can be used to explain how an investor holding Abcellera can time the market purely based on public headlines and social activities around Abcellera BiologicsInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Abcellera BiologicsInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abcellera BiologicsInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abcellera BiologicsInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abcellera BiologicsInc.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abcellera BiologicsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abcellera BiologicsInc's short interest history, or implied volatility extrapolated from Abcellera BiologicsInc options trading.
Check out Abcellera BiologicsInc Backtesting and Abcellera BiologicsInc Hype Analysis. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Abcellera Stock analysis
When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.51) | Revenue Per Share 0.131 | Quarterly Revenue Growth (0.57) | Return On Assets (0.1) |
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.